Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Avicennia marina heartwood extract shows strong antioxidant potential for health benefits.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Certain genetic variants in ERN1, TACR3, and SPPL2C are linked to when Alzheimer's disease starts.

Certain genetic variants in PRLR and PCCA genes may lead to shorter hair in cattle, which could help with heat tolerance.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

The DNMT3B -579G>T polymorphism may increase the risk of colorectal cancer.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

RALF22 is essential for root hair growth in response to fungal emissions in Arabidopsis.

All four treatments for early rheumatoid arthritis had similar safety profiles.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

The method effectively measures drug impact on DHT levels in prostate treatments.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.